[Disturbances of oxidative metabolism in congestive heart failure. Possibility of pharmacologic protection].
In 20 patients with congestive heart failure, a significant increase in malonyldialdehyde (MDA) plasma concentration, decrease in GSH-Px plasma activity and decrease in selenium (Se) concentration in plasma and whole blood were found. We discussed possibility of pharmacological protection in observed oxidative metabolism disturbances.
Kowalski
J
J
Kliniki Chorób Płuc, Lodzi.
Pawlicki
L
L
Kopff
M
M
Wasowicz
W
W
D000368:Aged; D005260:Female; D005979:Glutathione Peroxidase / Q000097:blood; D006333:Heart Failure / Q000378:metabolism* / Q000517:prevention & control; D006801:Humans; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D008875:Middle Aged; D010101:Oxygen Consumption; D012643:Selenium / Q000097:blood
D008315:Malondialdehyde; D005979:Glutathione Peroxidase; D012643:Selenium
Zaburzenia metabolizmu tlenowego w zastoinowej niewydolności serca. Mozliwości ochrony farmakologicznej.